Your browser doesn't support javascript.
loading
The efficacy of single-high dose inhaled corticosteroid versus oral prednisone treatment on exhaled leukotriene and 8-isoprostane levels in mild to moderate asthmatic children with asthma exacerbation
Keskin, O; Uluca, U; Keskin, M; Gogebakan, B; Kucukosmanoglu, E; Ozkars, MY; Kul, S; Bayram, H; Coskun, Y.
Affiliation
  • Keskin, O; Gaziantep University School of Medicine. Department of Pediatric Allergy and Immunology. Gaziantep. Turkey
  • Uluca, U; Gaziantep University School of Medicine. Department of Pediatrics. Gaziantep. Turkey
  • Keskin, M; Gaziantep University School of Medicine. Department of Pediatrics. Gaziantep. Turkey
  • Gogebakan, B; Gaziantep University School of Medicine. Department of Pulmonology. Gaziantep. Turkey
  • Kucukosmanoglu, E; Gaziantep University School of Medicine. Department of Pediatric Allergy and Immunology. Gaziantep. Turkey
  • Ozkars, MY; Gaziantep University School of Medicine. Department of Pediatric Allergy and Immunology. Gaziantep. Turkey
  • Kul, S; 1Gaziantep University School of Medicine. Department of Biostatistics. Gaziantep. Turkey
  • Bayram, H; Gaziantep University School of Medicine. Department of Pulmonology. Gaziantep. Turkey
  • Coskun, Y; Gaziantep University School of Medicine. Department of Pediatrics. Gaziantep. Turkey
Allergol. immunopatol ; 44(2): 138-148, mar.-abr. 2016. tab, graf
Article in En | IBECS | ID: ibc-150661
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
BACKGROUND: The anti-inflammatory effect of high-dose inhaled corticosteroids (ICS) in children with asthma exacerbation is unknown. We aimed to investigate the efficacy of single-high dose ICS versus oral prednisone treatment followed by a course of six day high-dose ICS or oral prednisone (P) treatment on the concentrations of Cys-LTs and 8-isoprostane levels in the exhaled breath condensate (EBC) of children with asthma exacerbation. METHODS: Ninety-four children with moderate-severe asthma exacerbation were evaluated with asthma scores, peak expiratory flow rate (PEF), forced expiratory volume in first second (FEV1) and exhaled Cys-LT and 8-isoprostane levels before and after treatment. EBC was collected from 52 patients before and four hours after treatment with inhaled fluticasone propionate (FP) (4000 μg) or P and after six days of treatment with FP-1000 μg/day or P. Cys-LTs and 8-isoprostane concentrations were determined using a specific immunoassay kit. RESULTS: Both single high-dose FP (n = 59) and p (n = 35) treatment resulted in a significant improvement in asthma score (p < 0.0001), PEF (p < 0.0001), and FEV1 (p < 0.0001). Cys-LT concentration in the EBC decreased significantly both after the initial treatment (p = 0.001), and at the end of the six-day period in the FP group (p < 0.0001). 8-Isoprostane concentration was lower only after six days of treatment with FP-1000 μg/day in the FP group (p = 0.023). There was a significant decrease in exhaled Cys-LTs after four hours (p = 0.012) and six days of P treatment (p = 0.018) in children with asthma exacerbation. CONCLUSIONS: High-dose ICS treatment may be useful in the treatment of children with asthma exacerbation. The effects start as early as after four hours. The suppression of Cys-LTs production contributes to the early effects. Suppression of both Cys-LTs and oxidants may favourably contribute to the effects observed later
RESUMEN
No disponible
Subject(s)
Search on Google
Collection: 06-national / ES Database: IBECS Main subject: Asthma / Prednisone / Leukotrienes / Adrenal Cortex Hormones / Isoprostanes Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Allergol. immunopatol Year: 2016 Document type: Article
Search on Google
Collection: 06-national / ES Database: IBECS Main subject: Asthma / Prednisone / Leukotrienes / Adrenal Cortex Hormones / Isoprostanes Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Allergol. immunopatol Year: 2016 Document type: Article